ADMA Biologics Inc (ADMA)
6.44
-0.02
(-0.31%)
USD |
NASDAQ |
Apr 25, 16:00
6.45
+0.01
(+0.16%)
After-Hours: 20:00
ADMA Biologics Cash from Operations (TTM): 8.80M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.80M |
| September 30, 2023 | -16.18M |
| June 30, 2023 | -41.44M |
| March 31, 2023 | -48.22M |
| December 31, 2022 | -59.51M |
| September 30, 2022 | -85.59M |
| June 30, 2022 | -85.72M |
| March 31, 2022 | -105.15M |
| December 31, 2021 | -112.37M |
| September 30, 2021 | -111.12M |
| June 30, 2021 | -121.56M |
| March 31, 2021 | -110.59M |
| December 31, 2020 | -102.00M |
| September 30, 2020 | -89.44M |
| June 30, 2020 | -89.21M |
| March 31, 2020 | -86.55M |
| December 31, 2019 | -76.19M |
| September 30, 2019 | -75.33M |
| June 30, 2019 | -64.25M |
| March 31, 2019 | -60.53M |
| December 31, 2018 | -62.68M |
| September 30, 2018 | -57.24M |
| June 30, 2018 | -54.44M |
| March 31, 2018 | -48.31M |
| December 31, 2017 | -37.27M |
| Date | Value |
|---|---|
| September 30, 2017 | -27.53M |
| June 30, 2017 | -22.47M |
| March 31, 2017 | -18.50M |
| December 31, 2016 | -18.27M |
| September 30, 2016 | -18.73M |
| June 30, 2016 | -16.72M |
| March 31, 2016 | -16.37M |
| December 31, 2015 | -15.42M |
| September 30, 2015 | -14.24M |
| June 30, 2015 | -14.04M |
| March 31, 2015 | -13.89M |
| December 31, 2014 | -14.70M |
| September 30, 2014 | -14.76M |
| June 30, 2014 | -14.52M |
| March 31, 2014 | -12.85M |
| December 31, 2013 | -10.89M |
| September 30, 2013 | -9.734M |
| June 30, 2013 | -9.61M |
| March 31, 2013 | -7.980M |
| December 31, 2012 | -6.904M |
| September 30, 2012 | -5.110M |
| June 30, 2012 | -3.014M |
| March 31, 2012 | -2.024M |
| December 31, 2011 | -0.0296M |
| September 30, 2011 | -0.0258M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-121.56M
Minimum
Jun 2021
8.80M
Maximum
Dec 2023
-77.45M
Average
-85.72M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
| Vanda Pharmaceuticals Inc | 12.80M |
| ANI Pharmaceuticals Inc | 118.96M |
| Ligand Pharmaceuticals Inc | 49.58M |
| Puma Biotechnology Inc | 27.01M |
| Bristol-Myers Squibb Co | 13.86B |